Annual Operating Expenses
$56.61 M
-$28.63 M-33.58%
December 31, 2022
Summary
- As of February 10, 2025, SGTX annual total operating expenses is $56.61 million, with the most recent change of -$28.63 million (-33.58%) on December 31, 2022.
- During the last 3 years, SGTX annual operating expenses has fallen by -$1.67 million (-2.86%).
Performance
SGTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$13.34 M
+$1.23 M+10.16%
June 30, 2023
Summary
- As of February 10, 2025, SGTX quarterly total operating expenses is $13.34 million, with the most recent change of +$1.23 million (+10.16%) on June 30, 2023.
- Over the past year, SGTX quarterly operating expenses has dropped by -$3.58 million (-21.18%).
Performance
SGTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
SGTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.6% | -21.2% |
| 3 y3 years | -2.9% | -12.7% |
| 5 y5 years | +104.3% | -25.6% |
SGTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.6% | at low | -30.8% | -22.2% |
| 5 y | 5-year | -33.6% | at low | -41.4% | -22.2% |
| alltime | all time | -33.6% | -51.0% | -41.4% | -22.2% |
Sigilon Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $13.34 M(+10.2%) |
| Mar 2023 | - | $12.11 M(+16.7%) |
| Dec 2022 | $56.61 M(-33.6%) | $10.37 M(-18.2%) |
| Sep 2022 | - | $12.68 M(-25.1%) |
| Jun 2022 | - | $16.92 M(+1.7%) |
| Mar 2022 | - | $16.64 M(-13.7%) |
| Dec 2021 | $85.23 M | $19.28 M(-11.1%) |
| Sep 2021 | - | $21.69 M(-4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $22.74 M(+5.7%) |
| Mar 2021 | - | $21.52 M(+20.6%) |
| Dec 2020 | $66.02 M(+13.3%) | $17.84 M(+6.5%) |
| Sep 2020 | - | $16.76 M(+9.8%) |
| Jun 2020 | - | $15.27 M(-5.4%) |
| Mar 2020 | - | $16.14 M(-9.9%) |
| Dec 2019 | $58.28 M(+110.3%) | $17.91 M |
| Dec 2018 | $27.71 M | - |
FAQ
- What is Sigilon Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Sigilon Therapeutics?
- What is Sigilon Therapeutics annual operating expenses year-on-year change?
- What is Sigilon Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Sigilon Therapeutics?
- What is Sigilon Therapeutics quarterly operating expenses year-on-year change?
What is Sigilon Therapeutics annual total operating expenses?
The current annual operating expenses of SGTX is $56.61 M
What is the all time high annual operating expenses for Sigilon Therapeutics?
Sigilon Therapeutics all-time high annual total operating expenses is $85.23 M
What is Sigilon Therapeutics annual operating expenses year-on-year change?
Over the past year, SGTX annual total operating expenses has changed by -$28.63 M (-33.58%)
What is Sigilon Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of SGTX is $13.34 M
What is the all time high quarterly operating expenses for Sigilon Therapeutics?
Sigilon Therapeutics all-time high quarterly total operating expenses is $22.74 M
What is Sigilon Therapeutics quarterly operating expenses year-on-year change?
Over the past year, SGTX quarterly total operating expenses has changed by -$3.58 M (-21.18%)